UBC is playing a key role in understanding and preventing chronic diseases like diabetes and arthritis. With a commitment to evidence-based practice, our researchers are generating new knowledge that is reshaping how we treat and manage complex diseases.
Spotlight
Using AI to enhance prevention of diabetes-related blindness
UBC researchers used AI to identify sex differences in diabetic retinopathy that could be essential for precision diagnostics and care.
Stem cell engineering breakthrough paves way for next-generation living drugs
UBC researchers discover how to grow specialized immune cells for more accessible off-the-shelf cell therapies to treat cancer, autoimmune disorders and more.
Northern Centre for Clinical Research launches first clinical trial
The trial provides people in northern communities the opportunity to participate in research on a potential treatment for chronic kidney disease.
A digestive ‘treasure chest’ shows promise for targeted drug treatment in the gut
UBC researchers have developed a new targeted drug delivery method for conditions like inflammatory bowel disease.
Proteins and fats can drive insulin production for some, paving way for tailored nutrition
New UBC Medicine research shows how insulin-triggering nutrients vary from person to person.
Aging well is connected to hearing well
New UBC study examines the link between hearing loss and activity levels.
A safer treatment path for high-risk children to overcome food allergies
New UBC research highlights safety and efficacy of sublingual immunotherapy for older and high-risk children with food allergies.
Endometriosis: Towards better diagnosis and treatment
UBC’s Dr. Paul Yong is helping ignite change for thousands of people faced with the painful disorder.
Stem cell-based treatment controls blood sugar in people with Type 1 diabetes
A clinical trial led by UBC researchers shows that an innovative treatment can help reduce dependence on insulin injections for people with Type 1 diabetes.
Helping British Columbians see clearly
Clinical researcher Dr. Eduardo Navajas is part of the first clinical trial for a gene therapy to treat wet age-related macular degeneration.